Pfizer, Inc.

Equities

PFE

US7170811035

Pharmaceuticals

Market Closed - Nyse 04:00:39 2024-04-23 pm EDT After market 04:20:18 pm
26.32 USD +0.23% Intraday chart for Pfizer, Inc. 26.32 -0.02%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Edwards Lifesciences Corporation: The story continues Our Logo
Pfizer vs Moderna battle over COVID vaccine patents begins in UK RE
Pfizer: new Emblaveo antibiotic approved in the EU CF
Pfizer's Emblaveo Receives European Commission Marketing Approval MT
European Commission Approves Pfizer?s Emblaveo® for Patients with Multidrug-Resistant Infections and Limited Treatment Options CI
Sector Update: Health Care Stocks Retreating Late Afternoon MT
Sector Update: Health Care MT
Connect Biopharma Terminates Agreement on Antiallergic Candidate With Pfizer MT
Tara Health Foundation Files an Exempt Solicitation Statement with Securities and Exchange Commission CI
News Highlights : Top Financial Services News of the Day - Monday at 11 AM ET DJ
Global markets live: Goldman Sachs, Apple, Salesforce, Boeing Tesla... Our Logo
Novavax Shareholder Shah Capital Pushes to Add 2 Nominees to Company's Board MT
Market outlook is uncertain, but optimism prevails Our Logo
News Highlights : Top Financial Services News of the Day - Monday at 7 AM ET DJ
News Highlights : Top Financial Services News of the Day - Monday at 12 AM ET DJ
PFIZER INC : JP Morgan remains Neutral ZD
Skanska Trims Scope of Work for Biomanufacturing Facility Project in US MT
PFIZER INC : Berenberg remains Neutral ZD
Health Care Stocks Steady, Moderna Climbs -- Health Care Roundup DJ
Sector Update: Health Care Stocks Mixed in Late Afternoon Trading MT
Sector Update: Health Care MT
Pfizer Says Phase 3 Trial of Abrysvo for Respiratory Syncytial Virus Disease Meets Primary Endpoints MT
Pfizer's RSV Vaccine Meets Primary Endpoints in Study of Participants Under 60 Years; Seeks Expanded Access MT
Pfizer: positive results for RSV in adults CF
Pfizer's Abrysvo Hits Key Goals in Adults at Increased RSV Risk DJ
Chart Pfizer, Inc.
More charts
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
26.26 USD
Average target price
31.62 USD
Spread / Average Target
+20.41%
Consensus
  1. Stock Market
  2. Equities
  3. PFE Stock
  4. News Pfizer, Inc.
  5. Pfizer Denies Claims of Funding Misinformation Against AstraZeneca's COVID-19 Jab